SLEEP AND BREATHING - CENTRAL SLEEP-APNEA, PATHOGENESIS AND TREATMENT - AN OVERVIEW AND PERSPECTIVE

被引:56
作者
DEBACKER, WA
机构
[1] Department Pulmonary Medicine, University of Antwerp, 2610 Wilrijk-Antwerpen
关键词
CENTRAL SLEEP APNEA; CHEMICAL DRIVE; CONTROL OF BREATHING;
D O I
10.1183/09031936.95.08081372
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The prevalence of reported sleep disturbances in a general population is high, Many of the complaints are the result of sleep-related breathing disorders, due mainly to the occurrence of obstructive and central apnoeas, Obstructive sleep apnoea is a fully described and well-recognized entity, Central sleep apnoea (CSA) however, has been poorly studied. There is accumulating evidence that central sleep apnoea should be considered as the end of a spectrum, Instability in the breathing pattern is the main underlying mechanism and is due to the interaction of many factors, Breathing during sleep is dependent on metabolic control and the activity of the respiratory muscles, Decreased chemical drive and/or failing respiratory muscle function are associated with CSA and usually also with ongoing hypoventilation during wakefulness, characterized by chronic daytime hypercapnia Central respiratory drive can also be inhibited by upper airway reflexes, Mostly, however, CSA occurs as the hallmark of unstable breathing during sleep brought about by an overall increase in loop gain (especially in light sleep stages) and the unmasking of a CO2 threshold. Arousal following central apnoeas acts as an amplification of the instability, Micro electroencephographic (EEG) arousals are often observed as a consequence of CSA, They are responsible for sleep fragmentation and hypersomnolence during the day, The daytime hypersomnolence and complaints of awakenings during sleep in patients with CSA can be striking, CSA can occur in specific pathologies, such as chronic heart failure and (post-traumatic) brain lesions, that are associated with irregular breathing. Treatment strategies are remarkably few in number, Use of nasal ventilation and the inhalation of CO2 are mainly of theoretical interest, since patients do not often tolerate these more invasive therapies, Drug treatment, especially with acetazolamide, is easier to perform, Stimulation of upper airway reflexes, by less invasive methods, seems to be promising for the near future.
引用
收藏
页码:1372 / 1383
页数:12
相关论文
共 117 条
[31]   CHEYNE-STOKES RESPIRATION PRESENTING AS SLEEP-APNEA SYNDROME - CLINICAL AND POLYSOMNOGRAPHIC FEATURES [J].
DOWDELL, WT ;
JAVAHERI, S ;
MCGINNIS, W .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (04) :871-879
[32]  
DUTTON K, 1989, J APPL PHYSIOL, V67, P517
[33]  
EICHENHORN MS, 1983, AM REV RESPIR DIS, V128, P765
[34]   DOMICILIARY NOCTURNAL NASAL INTERMITTENT POSITIVE PRESSURE VENTILATION IN HYPERCAPNIC RESPIRATORY-FAILURE DUE TO CHRONIC OBSTRUCTIVE LUNG-DISEASE - EFFECTS ON SLEEP AND QUALITY-OF-LIFE [J].
ELLIOTT, MW ;
SIMONDS, AK ;
CARROLL, MP ;
WEDZICHA, JA ;
BRANTHWAITE, MA .
THORAX, 1992, 47 (05) :342-348
[35]  
FELDMAN JL, 1995, REGULATION BREATHING, P39
[36]   SNORING AND NOCTURNAL OXYGEN DESATURATIONS IN AN ITALIAN MIDDLE-AGED MALE-POPULATION - EPIDEMIOLOGIC-STUDY WITH AN AMBULATORY DEVICE [J].
FERINISTRAMBI, L ;
ZUCCONI, M ;
PALAZZI, S ;
CASTRONOVO, V ;
OLDANI, A ;
DELLAMARCA, G ;
SMIRNE, S .
CHEST, 1994, 105 (06) :1759-1764
[37]  
FLEETHAM JA, 1980, AM REV RESPIR DIS, V122, P583
[38]   ROLE OF NOCTURNAL OXYGEN-THERAPY IN OBSTRUCTIVE SLEEP-APNEA - WHEN SHOULD IT BE USED [J].
FLETCHER, EC ;
MUNAFO, DA .
CHEST, 1990, 98 (06) :1497-1504
[39]   EFFECT OF ACETAZOLAMIDE ON CEREBRAL BLOOD-FLOW AND CAPILLARY PATENCY [J].
FRANKEL, HM ;
GARCIA, E ;
MALIK, F ;
WEISS, JK ;
WEISS, HR .
JOURNAL OF APPLIED PHYSIOLOGY, 1992, 73 (05) :1756-1761
[40]   AMINOPHYLLINE EFFECTS ON VENTILATORY RESPONSE TO HYPOXIA AND HYPEROXIA IN NORMAL ADULTS [J].
GEORGOPOULOS, D ;
HOLTBY, SG ;
BEREZANSKI, D ;
ANTHONISEN, NR .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 67 (03) :1150-1156